Cargando…
Comparing the economic terms of biotechnology licenses from academic institutions with those between commercial firms
Licenses of drug-related biotechnologies from academic institutions to commercial firms are intended to promote practical applications of public sector research and a return on government investments in biomedical science. This empirical study compares the economic terms of 239 biotechnology license...
Autores principales: | Shah, Prateet, Vaughan, Gregory, Ledley, Fred D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065281/ https://www.ncbi.nlm.nih.gov/pubmed/37000836 http://dx.doi.org/10.1371/journal.pone.0283887 |
Ejemplares similares
-
Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms
por: Sheikhan, Natasha Y., et al.
Publicado: (2021) -
Translational Science by Public Biotechnology Companies in the IPO“Class of 2000”: The Impact of Technological Maturity
por: McNamee, Laura, et al.
Publicado: (2013) -
Main challenges in developing biotechnology industry in Malaysia: perspectives from the innovative biotechnology firms
por: Abuduxike, Gulifeiya, et al.
Publicado: (2012) -
A multi-institutional partnership catalyzing the commercialization of medical devices and biotechnology products
por: Hafer, Nathaniel, et al.
Publicado: (2021) -
Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry
por: Zhou, Edward W., et al.
Publicado: (2023)